
Researchers looking at peptide literature often encounter TB-500 and BPC-157 in the same research discussions. That does not mean they are the same type of peptide, share the same sequence, or should be treated as interchangeable research materials.
TB-500 is associated with a synthetic peptide sequence derived from a region of thymosin beta-4, while BPC-157 is a distinct 15-amino-acid peptide known in the literature as a fragment of body protection compound. Published analytical studies have characterized both materials using techniques such as liquid chromatography and mass spectrometry.
For researchers and laboratories, the important question is therefore not simply “TB-500 vs BPC-157: which is better?” A more useful question is: What exactly does each name represent, and how can the identity of the research material be verified?
TB-500 vs BPC-157: What Is the Difference?
TB-500 and BPC-157 are two different peptide research materials with different molecular identities.
Published analytical literature describes TB-500 in connection with N-acetylated LKKTETQ, a seven-amino-acid sequence corresponding to residues 17–23 of thymosin beta-4. A 2012 study identified the N-terminally acetylated fragment Ac-LKKTETQ in material identified as TB-500 using high-performance liquid chromatography and high-resolution mass spectrometry.
BPC-157, by comparison, is a 15-amino-acid peptide. Published analytical work gives its sequence as:
GEPPPGKPADDAGLV
A 2017 analytical study identified BPC-157 in confiscated peptide vials and reported this 15-amino-acid sequence.
That difference is important.
TB-500 and BPC-157 should not be treated as two names for the same molecule. Their sequences, molecular characteristics and research histories are distinct.
Quick comparison
| Characteristic | TB-500 | BPC-157 |
| Research terminology | TB-500 | BPC-157 |
| Sequence commonly identified in analytical literature | Ac-LKKTETQ | GEPPPGKPADDAGLV |
| Sequence length | 7 amino acids | 15 amino acids |
| Molecular relationship | Associated with a region of thymosin beta-4 | Fragment associated with body protection compound |
| Analytical methods in published research | HPLC, LC-MS, HRMS | LC-MS and related analytical methods |
| Key research consideration | Exact sequence and acetylation status | Exact sequence and molecular identity |
The comparison shows why peptide terminology needs to be handled carefully. A product name provides a starting point, but it is not a substitute for molecular specifications.

What Is TB-500 in Research Terminology?
The scientific and analytical literature commonly describes TB-500 as a synthetic peptide related to the active region of thymosin beta-4.
One important paper investigated material identified as TB-500 and reported the detection of N-terminally acetylated Ac-LKKTETQ, corresponding to residues 17–23 of thymosin beta-4. The researchers used HPLC combined with high-resolution mass spectrometry to identify the compound.
Another analytical study described TB-500 as a synthetic version of the naturally occurring peptide sequence LKKTETQ, with artificial N-terminal acetylation.
This distinction matters because discussions about TB-500 sometimes use the terms TB-500, thymosin beta-4, Tβ4, and thymosin beta-4 fragment too loosely.
From a research perspective, these terms should not automatically be considered interchangeable.
The most useful specification is the actual molecular description:
- Exact amino-acid sequence
- Terminal modifications
- Molecular mass
- Chemical form
- Purity specification
- Analytical characterization
Why the Ac-LKKTETQ sequence matters
The sequence LKKTETQ corresponds to residues 17–23 of thymosin beta-4. The TB-500 literature has specifically investigated the N-terminally acetylated form, Ac-LKKTETQ.
That makes acetylation an important part of the terminology.
A peptide with the same underlying amino-acid sequence but a different terminal chemical form may not have the same molecular specification. Researchers therefore need to distinguish between the peptide sequence itself and any chemical modifications attached to it.
What Is BPC-157 in Research Terminology?
BPC-157 is a distinct peptide that has been described in the scientific literature as a 15-amino-acid fragment of body protection compound.
Published research identifies the sequence as:
GEPPPGKPADDAGLV
A 2011 study described BPC-157 as a 15-amino-acid peptide and characterized it as a partial sequence of body protection compound.
Earlier literature also described BPC-157 as a 15-amino-acid fragment associated with BPC.
Analytical terminology is particularly useful here because BPC-157 has a recognizable sequence that can be distinguished from unrelated peptide materials.
For laboratory documentation, researchers should therefore look beyond the label “BPC-157 peptide” and confirm that the documented sequence and analytical information correspond to the intended material.
TB-500 vs BPC-157: Sequence Matters
One of the simplest ways to understand the difference between TB-500 and BPC-157 is to look at their sequences.
TB-500
Ac-LKKTETQ
BPC-157
GEPPPGKPADDAGLV
These sequences are clearly different in both composition and length.
TB-500-related analytical literature identifies a seven-amino-acid sequence with N-terminal acetylation, while BPC-157 is documented as a 15-amino-acid peptide.

This is why the phrase “TB-500 vs BPC-157” should be understood as a comparison between two distinct peptide materials rather than two versions of the same compound.
For research procurement and documentation, sequence information is often much more informative than marketing terminology.
How Researchers Verify TB-500 and BPC-157 Identity
Analytical characterization plays an important role in peptide research.
HPLC
High-performance liquid chromatography, commonly abbreviated as HPLC, can be used to separate peptide-related components and examine chromatographic profiles.
For research material evaluation, HPLC data can provide useful information about chromatographic purity and the presence of detectable components.
However, an HPLC chromatogram should not be interpreted in isolation as absolute proof of molecular identity.
Mass Spectrometry
Mass spectrometry provides information about molecular mass and can support peptide identification.
The published TB-500 analytical study used high-performance liquid chromatography coupled with high-resolution mass spectrometry to identify Ac-LKKTETQ.
A separate study examining BPC-157 also used mass-spectrometric analytical approaches to identify the peptide in confiscated material.
Why HPLC and MS work better together
HPLC and mass spectrometry answer different analytical questions.
HPLC helps researchers examine chromatographic separation and related purity characteristics, while mass spectrometry provides molecular-mass information that can support identity assessment.
For this reason, a research specification supported by multiple analytical measurements can provide more useful information than a peptide name alone.

A More Recent Look at TB-500 Analytical Research
TB-500 characterization has continued beyond the original 2012 analytical reports.
A 2024 study developed and validated a method for simultaneously quantifying TB-500 and its metabolites using UHPLC-Q-Exactive Orbitrap mass spectrometry. The researchers examined TB-500 metabolism and reported several metabolites in experimental systems.
This study is useful from an analytical perspective because it demonstrates how modern mass-spectrometry platforms can be used to investigate not only a parent peptide but also its related molecular products.
For peptide research, this highlights an important principle:
The more precise the research question, the more important molecular characterization becomes.
A simple product label may be sufficient for basic catalog identification, but detailed laboratory work requires more precise information about sequence, chemical form and analytical behavior.
TB-500 vs BPC-157: Why Product Specifications Matter
Researchers evaluating peptide research material should look beyond the name printed on a vial or catalog page.
A useful specification review can include:
1. Exact peptide name
Confirm the exact material designation rather than relying on abbreviated terminology.
2. Amino-acid sequence
The sequence should correspond to the intended peptide.
For example:
TB-500-related sequence: Ac-LKKTETQ
BPC-157 sequence: GEPPPGKPADDAGLV
3. Chemical modifications
Terminal acetylation and other modifications can be important components of peptide identity.
The TB-500 literature specifically identifies the N-terminally acetylated form Ac-LKKTETQ.
4. Molecular mass
Expected molecular mass provides another analytical parameter for identity verification.
5. HPLC data
Chromatographic data can help characterize the material and assess its reported purity profile.
6. Mass spectrometry
MS or HRMS data can provide additional evidence supporting molecular identity.
7. Lot-specific documentation
For research procurement, lot or batch information helps connect analytical documentation to the specific material being evaluated.

TB-500 vs BPC-157: Key Differences at a Glance
| Research characteristic | TB-500 | BPC-157 |
| Peptide category | Synthetic peptide related to a region of thymosin beta-4 | 15-amino-acid peptide associated with body protection compound |
| Commonly documented sequence | Ac-LKKTETQ | GEPPPGKPADDAGLV |
| Amino-acid count | 7 in the commonly characterized TB-500 fragment | 15 |
| Modification of note | N-terminal acetylation | Sequence-specific molecular identity |
| Research terminology | TB-500, thymosin beta-4-related fragment | BPC-157, pentadecapeptide |
| Analytical research | HPLC, HRMS, LC-MS | LC-MS and related analytical methods |
| Primary verification focus | Sequence, acetylation, molecular mass, analytical profile | Sequence, molecular mass, analytical profile |
The most important point is simple: TB-500 and BPC-157 are not interchangeable peptide names.
Their molecular identities are different, their sequences are different, and their research literature has developed around different analytical and biological questions.
Shocking Research Fact: The Same Peptide Name Can Hide Important Chemical Details
Peptide terminology can become confusing when shortened names are used without a complete specification.
Consider TB-500.
The analytical literature did not simply describe an unidentified substance as “TB-500.” It investigated the material at the molecular level and identified N-terminally acetylated Ac-LKKTETQ using chromatographic and mass-spectrometric methods.
That distinction demonstrates why researchers should ask:
What sequence?
What chemical form?
What molecular mass?
What analytical evidence?
These questions are especially important when comparing research peptides from different sources.
What Should Researchers Look for When Comparing Peptide Materials?
A practical research-material checklist can be summarized in five steps:
1. Identify the peptide
Confirm the exact product designation.
2. Confirm the sequence
Check the documented amino-acid sequence.
3. Review chemical modifications
Look for acetylation or other stated modifications.
4. Examine analytical information
Review available HPLC, MS or HRMS data.
5. Match the documentation to the lot
Where available, verify that the analytical documentation corresponds to the specific batch or lot being evaluated.
This approach helps separate research terminology from molecular identity.
Frequently Asked Questions
Is TB-500 the same as BPC-157?
No. TB-500 and BPC-157 are different peptide research materials with different sequences and molecular identities.
What is the TB-500 sequence?
Published analytical research has identified TB-500 in connection with the N-terminally acetylated sequence Ac-LKKTETQ, corresponding to residues 17–23 of thymosin beta-4.
What is the BPC-157 sequence?
Published analytical literature identifies BPC-157 as the 15-amino-acid sequence GEPPPGKPADDAGLV.
How many amino acids are in BPC-157?
BPC-157 is described in the scientific literature as a 15-amino-acid peptide, which is why it is also referred to as a pentadecapeptide.
Is TB-500 a fragment of thymosin beta-4?
Published analytical studies associate TB-500 with the 17–23 region of thymosin beta-4, specifically the sequence LKKTETQ and its N-terminally acetylated form Ac-LKKTETQ.
Why is HPLC important for peptide research?
HPLC can help characterize a peptide material’s chromatographic profile and provide information relevant to purity assessment. It is often more informative when considered alongside additional analytical methods.
Why is mass spectrometry used for peptide characterization?
Mass spectrometry can provide molecular-mass information that helps support peptide identity. Published TB-500 research has used high-resolution mass spectrometry alongside HPLC for molecular characterization.
What should a peptide COA contain?
For research purposes, useful documentation may include the peptide name, sequence or molecular specification, reported purity, analytical method, molecular-mass information where applicable, lot number and testing information. The exact contents depend on the material and testing laboratory.

Final Research Perspective
TB-500 and BPC-157 are often discussed together because both appear frequently in peptide research conversations, but their molecular identities are clearly different.
TB-500 is associated in published analytical literature with the N-terminally acetylated thymosin beta-4-related sequence Ac-LKKTETQ, while BPC-157 is a distinct 15-amino-acid peptide with the sequence GEPPPGKPADDAGLV.
For researchers, the most useful distinction is therefore not simply the product name. It is the combination of sequence, chemical form, molecular mass and analytical evidence.
When evaluating research peptides, terminology should always be supported by appropriate documentation and characterization.
Research Use Notice
Paradigm Peptides provides peptide materials for laboratory and research purposes only. The information in this article is provided for scientific and educational discussion and should not be interpreted as medical advice, treatment guidance, or instructions for human or veterinary use. Researchers should follow applicable laws, institutional requirements, laboratory protocols and safety procedures when working with research materials.